XML 66 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Instruments - Schedule of Cash Equivalents and Available-for-Sale Investments (Details) - USD ($)
$ in Millions
Apr. 30, 2023
Oct. 31, 2022
Cash Equivalents:    
Cost $ 981 $ 2,193
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 981 2,193
Available-for-Sale Investments:    
Cost 44 55
Gross Unrealized Gain 12 8
Gross Unrealized Loss 0 0
Fair Value 56 63
Total cash equivalents and available-for-sale investments, Cost 1,025 2,248
Total cash equivalents and available-for-sale investments, Gross Unrealized Gain 12 8
Total cash equivalents and available-for-sale investments, Gross Unrealized Loss 0 0
Total cash equivalents and available-for-sale investments, Fair Value 1,037 2,256
Corporate debt    
Cash Equivalents:    
Cost 607 904
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 607 904
Government debt    
Cash Equivalents:    
Cost 374 1,289
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 374 1,289
Financial institution instruments    
Available-for-Sale Investments:    
Debt securities, cost 3 5
Debt securities, Gross Unrealized Gain 0 0
Debt securities, Gross Unrealized Loss 0 0
Debt securities, Fair value 3 5
Marketable securities and mutual funds    
Available-for-Sale Investments:    
Equity securities, Cost 41 50
Equity securities, Gross Unrealized Gain 12 8
Equity securities, Gross Unrealized Loss 0 0
Equity securities, Fair Value $ 53 $ 58